# NIH Reporter #3U19NS132301-04S1

LEAD PROJECT 1: PHENYLKETONURIA (PKU)

**Recipient:** Children's Hospital of Philadelphia

**Award Amount:** $5,455,342.00
**Ceiling:** $5,455,342.00

**Awarded:** August 19, 2026

**Identifier:** 3U19NS132301-04S1

Funding supports development of lipid nanoparticle adenine base-editing treatments for PKU and urea cycle disorders, including planned clinical trial preparation.

### Description

Development of lipid nanoparticle-based adenine base-editing treatments for phenylketonuria or urea cycle disorders, with the goal of filing IND applications and conducting a phase I/II master protocol clinical trial for subjects with urea cycle disorders.

[View original record](https://reporter.nih.gov/search/Z6-pLStXck6naeyMsC9RTw/project-details/11421632)
